CoChat

A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates

Open access
Tachmazidou, Ioanna, Dedoussis, George, Southam, Lorraine, Farmaki, Aliki-Eleni, Ritchie, Graham R. S., Xifara, Dionysia K., Matchan, Angela, Hatzikotoulas, Konstantinos, Rayner, Nigel W., Chen, Yuan, Pollin, Toni I., O’Connell, Jeffrey R., Yerges-Armstrong, Laura M., Kiagiadaki, Chrysoula, Panoutsopoulou, Kalliope, Schwartzentruber, Jeremy, Moutsianas, Loukas, UK10K consortium, Tsafantakis, Emmanouil, Tyler-Smith, Chris, McVean, Gil, Xue, Yali, Zeggini, Eleftheria · 2013 · Nature Communications
Cited by 96

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Isolated populations can empower the identification of rare variation associated with complex traits through next generation association studies, but the generalizability of such findings remains unknown. Here we genotype 1,267 individuals from a Greek population isolate on the Illumina HumanExome Beadchip, in search of functional coding variants associated with lipids traits. We find genome-wide significant evidence for association between R19X, a functional variant in APOC3, with increased high-density lipoprotein and decreased triglycerides levels. Approximately 3.8% of individuals are heterozygous for this cardioprotective variant, which was previously thought to be private to the Amish founder population. R19X is rare (<0.05% frequency) in outbred European populations. The increased frequency of R19X enables discovery of this lipid traits signal at genome-wide significance in a small sample size. This work exemplifies the value of isolated populations in successfully detecting transferable rare variant associations of high medical relevance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms3872

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 23

  1. Peltonen, L., Palotie, A. & Lange, K. Use of population isolates for mapping complex traits. Nat. Rev. Genet. 1, 182–190 (2000). · DOI · Paper page
  2. Zeggini, E. Next-generation association studies for complex traits. Nat. Genet. 43, 287–288 (2011). · DOI · Paper page
  3. Huyghe, J. R. et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat. Genet. 45, 197–201 (2013). · DOI · Paper page
  4. Keys, A. Coronary Heart Disease in seven countries. Circulation 41, 1–211 (1970). · DOI · Paper page
  5. Menotti, A. et al. Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur. J. Epidemiol. 15, 507–515 (1999). · DOI · Paper page
  6. Renaud, S. et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am. J. Clin. Nutr. 61, 1360S–1367S (1995). · DOI · Paper page
  7. Aulchenko, Y. S. et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41, 47–55 (2009). · DOI · Paper page
  8. Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2009). · DOI · Paper page
  9. Ridker, P. M. et al. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: genomewide analysis among 18 245 initially healthy women from the Women’s Genome Health Study. Circ. Cardiovasc. Genet. 2, 26–33 (2009). · DOI · Paper page
  10. Smith, E. N. et al. Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet. 6, (2010). · DOI · Paper page
  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001). · DOI · Paper page
  12. Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012). · DOI · Paper page
  13. Fu, W. et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216–220 (2013). · DOI · Paper page
  14. Luttmann, S. et al. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient. J. Lipid. Res. 35, 1431–1440 (1994). · DOI · Paper page
  15. Maeda, H., Hashimoto, R. K., Ogura, T., Hiraga, S. & Uzawa, H. Molecular cloning of a human apoC-III variant: Thr 74—Ala 74 mutation prevents O-glycosylation. J. Lipid. Res. 28, 1405–1409 (1987). · DOI · Paper page
  16. Pullinger, C. R. et al. A novel apolipoprotein C-III variant, apoC-III(Gln38—>Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin. J. Lipid. Res. 38, 1833–1840 (1997). · DOI
  17. von Eckardstein, A. et al. Apolipoprotein C-III(Lys58—Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J. Clin. Invest. 87, 1724–1731 (1991). · DOI · Paper page
  18. Xu, C. F. et al. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin. Genet. 46, 385–397 (1994). · DOI · Paper page
  19. Dammerman, M., Sandkuijl, L. A., Halaas, J. L., Chung, W. & Breslow, J. L. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc. Natl Acad. Sci. USA 90, 4562–4566 (1993). · DOI · Paper page
  20. Talmud, P. J. et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039–3046 (2002). · DOI · Paper page
  21. Waterworth, D. M. et al. Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim. Biophys. Acta. 1637, 200–206 (2003). · DOI
  22. Atzmon, G. et al. Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol. 4, e113 (2006). · DOI · Paper page
  23. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972). · DOI · Paper page

Cited by

Metadata

Authors
Tachmazidou, I., Dedoussis, G., Southam, L., Farmaki, A.-E., Ritchie, G. R. S., Xifara, D. K., Matchan, A., Hatzikotoulas, K., Rayner, N. W., Chen, Y., Pollin, T. I., O’Connell, J. R., Yerges-Armstrong, L. M., Kiagiadaki, C., Panoutsopoulou, K., Schwartzentruber, J., Moutsianas, L., UK10K consortium, Tsafantakis, E., Tyler-Smith, C., McVean, G., Xue, Y., & Zeggini, E.
Venue
Nature Communications
Published
2013-12-17
Volume
4
Issue
1
Pages
2872-2872
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2026187919
Cited by
96
References
7
FWCI
7.84
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.